Diagnosis of malignant early detection of cancer. Medical search. Images

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Breast Prostate Feces Neoplastic Cells, Circulating Neoplastic Stem Cells Tumor Cells, Cultured Lymph Nodes Sputum

Organisms1

Diseases49

Breast Neoplasms Prostatic Neoplasms Lung Neoplasms Ovarian Neoplasms Neoplasms Pancreatic Neoplasms Stomach Neoplasms Colonic Neoplasms Uterine Cervical Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Disease Progression Carcinoma, Squamous Cell Colorectal Neoplasms Carcinoma Precancerous Conditions Genetic Predisposition to Disease Urinary Bladder Neoplasms Mouth Neoplasms Adenocarcinoma Neoplasm Recurrence, Local Skin Neoplasms Carcinoma, Non-Small-Cell Lung Liver Neoplasms Esophageal Neoplasms Rectal Neoplasms Melanoma Cell Transformation, Neoplastic Endometrial Neoplasms Head and Neck Neoplasms Bone Neoplasms Neoplasms, Second Primary Carcinoma in Situ Gastrointestinal Neoplasms Adenoma Pharyngeal Neoplasms Neoplastic Cells, Circulating Thyroid Neoplasms Neoplasms, Radiation-Induced Neoplasms, Glandular and Epithelial Neoplasms, Multiple Primary Carcinoma, Pancreatic Ductal Papillomavirus Infections Disease Models, Animal Recurrence Kidney Neoplasms Carcinoma, Small Cell Carcinoma, Hepatocellular Brain Neoplasms

Chemicals and Drugs31

Tumor Markers, Biological Neoplasm Proteins Biological Markers Prostate-Specific Antigen Antineoplastic Agents DNA, Neoplasm Cancer Vaccines RNA, Messenger DNA Primers Reagent Kits, Diagnostic Antigens, Neoplasm Antibodies, Monoclonal CA-125 Antigen Receptors, Estrogen Radiopharmaceuticals Receptor, erbB-2 MicroRNAs Tumor Suppressor Protein p53 Carcinoembryonic Antigen RNA, Small Interfering Cisplatin Fluorouracil Tamoxifen Receptors, Progesterone Genetic Markers Tumor Suppressor Proteins Antineoplastic Agents, Hormonal Antineoplastic Agents, Phytogenic Contrast Media DNA Probes Receptor, Epidermal Growth Factor

Analytical, Diagnostic and Therapeutic Techniques and Equipment109

Early Detection of Cancer Early Diagnosis Sensitivity and Specificity Polymerase Chain Reaction Reproducibility of Results Retrospective Studies Delayed Diagnosis Prognosis Predictive Value of Tests Prospective Studies Mass Screening Follow-Up Studies Risk Factors Limit of Detection Biopsy Neoplasm Staging Mammography ROC Curve Prenatal Diagnosis Reverse Transcriptase Polymerase Chain Reaction Tomography, X-Ray Computed Enzyme-Linked Immunosorbent Assay Survival Analysis Risk Assessment Survival Rate Incidence Registries False Positive Reactions Gene Expression Profiling Treatment Outcome Diagnosis, Computer-Assisted Risk Evaluation Studies as Topic Magnetic Resonance Imaging Questionnaires Molecular Diagnostic Techniques Diagnostic Errors Breast Self-Examination Immunoassay False Negative Reactions Immunoenzyme Techniques Diagnosis Prevalence Oligonucleotide Array Sequence Analysis Antineoplastic Combined Chemotherapy Protocols Odds Ratio Cohort Studies Reagent Kits, Diagnostic Genetic Testing Blotting, Western Combined Modality Therapy Immunohistochemistry Multivariate Analysis Diagnostic Imaging Logistic Models Self-Examination Bacteriological Techniques Biopsy, Needle Case-Control Studies Disease-Free Survival Xenograft Model Antitumor Assays Positron-Emission Tomography Neoplasm Transplantation Colonoscopy DNA Mutational Analysis Cross-Sectional Studies Kaplan-Meier Estimate SEER Program Chemotherapy, Adjuvant Real-Time Polymerase Chain Reaction Clinical Trials as Topic Pilot Projects Models, Biological Physical Examination Sequence Analysis, DNA Specimen Handling Feasibility Studies Flow Cytometry Biosensing Techniques Clinical Laboratory Techniques Neoplasm Grading Population Surveillance In Situ Hybridization, Fluorescence Protein Array Analysis Tumor Burden Confidence Intervals Fatal Outcome Neonatal Screening Papanicolaou Test Chi-Square Distribution Cluster Analysis Reference Values Nucleic Acid Amplification Techniques Transplantation, Heterologous Cytodiagnosis Radiotherapy Regression Analysis Staining and Labeling Statistics, Nonparametric Disease Models, Animal Tissue Array Analysis Ultrasonography Severity of Illness Index Chromatography, High Pressure Liquid Palpation Analysis of Variance Models, Statistical Occult Blood Dermoscopy

Psychiatry and Psychology4

Breast Self-Examination Smoking Self-Examination Preventive Psychiatry

Phenomena and Processes32

Sensitivity and Specificity Time Factors Gene Expression Regulation, Neoplastic Mutation Algorithms Genetic Predisposition to Disease Risk DNA Methylation Genotype Base Sequence Odds Ratio Pregnancy Drug Resistance, Neoplasm Phenotype Genes, BRCA1 Promoter Regions, Genetic Polymorphism, Genetic Cell Survival Chi-Square Distribution Dose-Response Relationship, Drug Down-Regulation Germ-Line Mutation Genes, Neoplasm Genetic Markers Genes, Tumor Suppressor Apoptosis Cell Proliferation Alleles Cell Movement Up-Regulation Gene Expression Cell Division

Disciplines and Occupations6

Immunohistochemistry Medical Oncology Proteomics Preventive Psychiatry Virology Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena4

National Cancer Institute (U.S.)Age Distribution Quality of Life Bioterrorism

Humanities1

Quality of Life

Information Science12

Survival Rate Incidence Registries Algorithms Diagnosis, Computer-Assisted Questionnaires Molecular Sequence Data Base Sequence Prevalence SEER Program Fatal Outcome Public Health Informatics

Named Groups2

Infant, Newborn Survivors

Health Care56

Sensitivity and Specificity Reproducibility of Results Retrospective Studies Predictive Value of Tests Prospective Studies Mass Screening Follow-Up Studies Risk Factors Limit of Detection ROC Curve Age Factors Survival Analysis Risk Assessment Survival Rate Incidence Registries Treatment Outcome Risk Evaluation Studies as Topic Questionnaires Diagnostic Errors National Cancer Institute (U.S.)Prevalence Odds Ratio Cohort Studies Genetic Testing Multivariate Analysis Logistic Models Case-Control Studies Disease-Free Survival Cross-Sectional Studies Kaplan-Meier Estimate SEER Program American Cancer Society Age Distribution Clinical Trials as Topic Pilot Projects Feasibility Studies Sex Factors Population Surveillance Confidence Intervals Fatal Outcome Neonatal Screening Chi-Square Distribution Cluster Analysis Disease Outbreaks Practice Guidelines as Topic Regression Analysis Statistics, Nonparametric Age of Onset Severity of Illness Index Analysis of Variance Models, Statistical Referral and Consultation Nursing Diagnosis Genetic Counseling

Geographicals7

United States Japan China India Iran Sweden Europe

No images available that match "diagnosis of malignant early detection of cancer"